Cediranib (Standard)

Overview

Cediranib (Standard) is the analytical standard of Cediranib. This product is intended for research and analytical applications. Cediranib (AZD2171) is a highly potent, orally available VEGFR tyrosine kinase inhibitor with IC 50 s of <1, <3, 5, 5, 36, 2 nM for Flt1, KDR, Flt4, PDGFRα , PDGFRβ , c-Kit , respectively.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Others | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > VEGFR | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > PDGFR

Product Information

• Catalog No.: HY-10205R
• CAS No.: 288383-20-0
• Molecular Formula: C25H27FN4O3
• Molecular Weight: 450.51
• Purity: 98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source